NCT04871490Completed
Improving Detection and Early Action for HPV-positive Oropharynx Cancer
Source: ClinicalTrials.gov · Last updated 5 Feb 2025
Brief summary (registry, in English)
This study aims to determine whether a blood test for HPV DNA can improve diagnosis of HPV-positive oropharynx cancer (HPV-OPC).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 29 Apr 2021
- Start date
- 24 Mar 2021
- Primary completion date
- 15 Dec 2022
- Lead sponsor
- Brigham and Women's Hospital
- Diseases
- Head and neck cancer
- NCT number
- NCT04871490
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 24 Mar 2021 to the primary completion date, 15 Dec 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Known diagnosis of HPV-OPC
Who the study is looking for
- Neck mass present for \>2 weeks with no signs/symptoms of infection
- Neck mass present for \>2 weeks with signs/symptoms of infection that did not resolve with antibiotic therapy
- Palatine or lingual tonsillar asymmetry on physical exam
- Palatine or lingual tonsillar asymmetry on imaging, including asymmetric FDG uptake in palatine or lingual tonsils on PET-CT scans
- Unexplained throat pain for \>2 weeks that did not resolve with antibiotic therapy
Age in the registry: 35 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Brigham and Women's Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.